(19)
(11) EP 4 211 253 A1

(12)

(43) Date of publication:
19.07.2023 Bulletin 2023/29

(21) Application number: 21867450.5

(22) Date of filing: 07.09.2021
(51) International Patent Classification (IPC): 
C12N 15/867(2006.01)
C12N 5/10(2006.01)
 C12N 15/63(2006.01)
C12N 5/0783(2010.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/86; C12N 2510/00; C12N 5/0646; C12N 2501/2302; C12N 2501/2315; C12N 2501/2321; C07K 14/005; C12N 2740/13043; C12N 2740/13022; C12N 2740/10022
(86) International application number:
PCT/US2021/049307
(87) International publication number:
WO 2022/055892 (17.03.2022 Gazette 2022/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.09.2020 US 202063075651 P
08.09.2020 US 202063075747 P

(71) Applicant: CytoImmune Therapeutics, Inc.
Wilmington, DE 19808 (US)

(72) Inventors:
  • ZHANG, Lei
    Wilmington, Delaware 19808 (US)
  • CHADA, Sunil
    Wilmington, Delaware 19808 (US)

(74) Representative: FRKelly 
27 Clyde Road
Dublin D04 F838
Dublin D04 F838 (IE)

   


(54) METHODS AND COMPOSITIONS OF INFECTING, ACTIVATING, AND EXPANDING IMMUNE CELLS